CpG methylation as a mechanism for the regulation of E2F activity - Wikidata - wikimedia - TriplyDB

CpG methylation as a mechanism for the regulation of E2F activity

CpG methylation as a mechanism for the regulation of E2F activity

http://www.wikidata.org/entity/Q35776918

about

Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF Human telomerase and its regulation Transcriptional and epigenetic regulation of the integrin collagen receptor locus ITGA1-PELO-ITGA2 CpG methylation plays a vital role in determining tissue- and cell-specific expression of the human cell-death-inducing DFF45-like effector A gene through the regulation of Sp1/Sp3 binding Epigenetic regulation of human alpha1d-adrenergic receptor gene expression: a role for DNA methylation in Sp1-dependent regulation Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implications Cross-talk between site-specific transcription factors and DNA methylation states Histone demethylase KDM4B regulates otic vesicle invagination via epigenetic control of Dlx3 expression.DNA methylation, its mediators and genome integrity Effects of methylation on expression of TMS1/ASC in human breast cancer cells Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture Characterization of the genomic Xist locus in rodents reveals conservation of overall gene structure and tandem repeats but rapid evolution of unique sequence Understanding transcriptional regulation by integrative analysis of transcription factor binding data.CpG methylation at the USF-binding site is important for the liver-specific transcription of the chipmunk HP-27 gene Conservation and regulatory associations of a wide affinity range of mouse transcription factor binding sites Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cells Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin?Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissues Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells Epigenetic upregulation of large-conductance Ca2+-activated K+ channel expression in uterine vascular adaptation to pregnancy Tissue-specific silencing of a transgene in rice Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood Perinatal nicotine exposure increases angiotensin II receptor-mediated vascular contractility in adult offspring.MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer.The Rb/chromatin connection and epigenetic control: opinion.The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms.Foetal nicotine exposure causes PKCε gene repression by promoter methylation in rat hearts.Analysis method of epigenetic DNA methylation to dynamically investigate the functional activity of transcription factors in gene expression.Analysis of intron sequence features associated with transcriptional regulation in human genes.Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation.The redox basis of epigenetic modifications: from mechanisms to functional consequences.High-resolution genome-wide DNA methylation maps of mouse primary female dermal fibroblasts and keratinocytes.Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer.A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types.Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma.Distribution and characterization of regulatory elements in the human genome.Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells Epigenetics and colorectal cancer

P2860

Q24306708-1663BF4B-2461-4CE7-83D5-78BEEEA84551 Q24533247-83CDAB8A-152E-4FCD-83D6-41670F114F68 Q24644093-D2859EB1-68DB-47C7-8738-D5B85D5ED3AC Q24645280-286DB9BF-628A-45C1-92C5-0727757BF139 Q24646956-B1B36FCB-7172-4D8D-9F7B-0FABAC72EC74 Q26783490-C262BAD4-84CB-4C0F-9E80-88D06DA4007D Q26860809-240DD58D-8174-426C-A988-8E7B3E5BB9A9 Q27309900-E44BC20F-1116-4461-9333-A5252EAAA107 Q28080760-C71C04C9-1573-43F1-A7D3-AEB7971AC59A Q28207669-5298A0C3-1786-4FB4-946C-7C85A5E688D9 Q28208766-4319078B-AC37-4120-BB6B-0893FDD3C733 Q28776438-7633A81F-93BF-4FC6-8EF5-EE67FAE5F9BA Q30562517-38AC7612-0172-4B9B-A98F-7950B0200EBE Q33231032-70DD69D3-37B3-4734-91CE-B320E8FE1D74 Q33524650-08469C9C-F8C7-40BD-8CA6-C65AF8E498C8 Q33705017-CA1C96DA-79F8-47CF-A153-C070B7B26A14 Q33729972-0E0C7553-275B-4975-BE14-B7C06447ACF7 Q33864653-F2CAA749-52DD-45F3-9E26-6B260108F3D5 Q33927036-15992C01-990E-4375-840D-550448A37413 Q34006827-F70F8DB5-9974-4BB9-B755-011DEF9FD196 Q34051563-76AF3C25-24F9-4AFA-AF16-E21AC48704C2 Q34076278-A1ED7404-A73C-43B1-B33E-34E5CB0195C5 Q34223830-55AF8AF1-19DF-45FE-9CA1-038DD9D0BC6D Q34263830-EEC6205B-6B7B-4FE7-A907-E94D8B3BC78B Q34288613-F76FA5AD-CBE6-4E4F-BB94-01EDD35CC811 Q34290306-8B9B5D89-B497-4313-A246-4323D23520D9 Q34318060-285F6743-F289-4645-999E-06B3578F9E0C Q34369723-41514814-C828-4EB3-AE05-D77CEBA8F5DB Q34410283-CBEC7B87-9C88-44F0-9D0B-95EC563D1E42 Q34433430-1A6C20F4-9B60-4B44-B46F-58C3F67CB018 Q34451925-BA76D59A-A963-4F32-B468-F8032A50943C Q34517696-E0CB8D32-6713-4319-BD91-C5F7E492B8A9 Q35055739-1B426266-6DF4-440F-B80F-25E3469B6AA4 Q35097312-BA460399-EC23-438B-A875-2C7BC73C884E Q35138892-B80F0A86-4F07-4A7C-8209-E4BAFB6FBC50 Q35162975-AA50405C-BC6B-4DF0-803F-1215E3253ADB Q35666522-D39CC865-76BE-4553-B589-BBF98B63812D Q35807015-03A0EBD8-1053-470F-BE99-C235962568FB Q35842503-56B07635-C395-4F93-B7F1-105D8C3AB87B Q36081553-60849900-BFB9-452C-A251-F9FA1F086ACA

P2860

CpG methylation as a mechanism for the regulation of E2F activity

http://www.wikidata.org/entity/Q35776918

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

CpG methylation as a mechanism for the regulation of E2F activity

@ast

CpG methylation as a mechanism for the regulation of E2F activity

@en

type

label

CpG methylation as a mechanism for the regulation of E2F activity

@ast

CpG methylation as a mechanism for the regulation of E2F activity

@en

prefLabel

CpG methylation as a mechanism for the regulation of E2F activity

@ast

CpG methylation as a mechanism for the regulation of E2F activity

@en

P1433

Q35776918-AA79CE37-286C-475F-ABC5-6152F7FBA8C1

P1476

Q35776918-F65D3F03-E5FD-469C-B03E-F26BF44C77A8

P2093

Q35776918-7B547B8F-4130-4FB6-A249-D0AE3147BFDB

Q35776918-B0DA1CC2-9F47-4B8B-8D44-2869B0C079AA

Q35776918-EB0BD7E8-CEA6-46EB-89F5-A21415B2F5EC

P2860

Q35776918-023047FA-09C8-4A83-AE5B-24BD7D1E8988

Q35776918-06AC4647-0F8C-4E8F-99C0-396413963143

Q35776918-0AC6DDA7-F254-4FB4-B7FA-673D10B9E278

Q35776918-1C1B596A-2D99-4502-8265-D4E2F1EBAA08

Q35776918-26E9EE90-F3E5-4435-B814-3AC1360EFF04

Q35776918-4549E180-1453-450D-8929-7F2EDE68BFA1

Q35776918-57DB1CE6-F233-4B89-A7EF-53097F243455

Q35776918-61B15028-671E-40BD-A4BD-5D9985063381

Q35776918-62911734-9976-40E7-85FC-A13779C97BB1

Q35776918-66DDB16B-CA67-437D-BE11-D1ABE1974791

P304

Q35776918-D7F37EE8-BE68-444D-AD1C-D3318235E143

P31

Q35776918-8D426CF8-4AE6-4F60-B37B-33A19D0ED3BC

P356

Q35776918-BDC459D9-9AE5-4705-83B1-1BD346E67EE0

P407

Q35776918-A18F82A1-11A9-44A0-A6C8-03D53C8827F7

P433

Q35776918-712F7CA9-7081-4048-9CD6-9440E453FF0C

P478

Q35776918-65735F67-AEE6-4278-A4B7-3D2B90DFC15E

P577

Q35776918-08CB4AAE-F41A-4B16-A8EC-0B33E7958BB2

P5875

Q35776918-A3DB30A7-43AF-4712-AEF6-61E4BC361CA0

P698

Q35776918-4FA694F7-05D8-43E7-BA49-38800C947615

P932

Q35776918-F3C290AD-B452-4C4A-87F0-B4C8A281E06C

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

CpG methylation as a mechanism for the regulation of E2F activity

@en

P2093

E K Flemington

http://www.w3.org/2001/XMLSchema#string

M I Armstrong

http://www.w3.org/2001/XMLSchema#string

M R Campanero

http://www.w3.org/2001/XMLSchema#string

P2860

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

The retinoblastoma protein and cell cycle control

CpG-rich islands and the function of DNA methylation

The regulation of E2F by pRB-family proteins

Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

Cancer cell cycles

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

Endogenous E2F-1 promotes timely G0 exit of resting mouse embryo fibroblasts.

Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production.

The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53.

P304

6481-6486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.100340697

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2000-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12493977

http://www.w3.org/2001/XMLSchema#string

P698

10823896

http://www.w3.org/2001/XMLSchema#string

P932

18629

http://www.w3.org/2001/XMLSchema#string